Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Tianda Pharmaceuticals Ltd. ( (HK:0455) ).
Tianda Pharmaceuticals Ltd. has announced a board meeting scheduled for March 28, 2025, to approve the company’s final results for the year ending December 31, 2024, and to consider the payment of a final dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential returns to shareholders, impacting its market positioning and stakeholder interests.
More about Tianda Pharmaceuticals Ltd.
Tianda Pharmaceuticals Ltd. is a company incorporated in the Cayman Islands with limited liability, operating in the pharmaceutical industry. It focuses on the development and distribution of pharmaceutical products and services.
YTD Price Performance: -1.18%
Average Trading Volume: 72,250
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$361.2M
For detailed information about 0455 stock, go to TipRanks’ Stock Analysis page.